Back to top
more

PharmaBio Serv (PBSV)

(Delayed Data from OTC)

$0.74 USD

0.74
5,317

0.00 (0.00%)

Updated Apr 25, 2024 01:28 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 28% (71 out of 252)

Industry: Consulting Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for PharmaBio Serv Inc falls in the month of October.

All items in Millions except Per Share data.

10/31/2023 10/31/2022 10/31/2021 10/31/2020 10/31/2019
Assets          
Cash & Equivalents 15 14 17 17 15
Receivables 4 5 5 10 9
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 0 1 1 2 2
Total Current Assets 19 20 23 29 26
Net Property & Equipment 0 0 0 0 0
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 0 0 0 0 0
Deposits & Other Assets 0 0 0 0 0
Total Assets 20 21 24 30 27
Liabilities & Shareholders Equity 10/31/2023 10/31/2022 10/31/2021 10/31/2020 10/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 1 2 2 2 2
Current Portion Long-Term Debt 0 0 0 1 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 1 0 0 0 0
Other Current Liabilities 0 0 0 0 2
Total Current Liabilities 2 2 3 4 4
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 1 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 2 2 2 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 4 4 5 7 6
Shareholders Equity 10/31/2023 10/31/2022 10/31/2021 10/31/2020 10/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2 2 1 1 1
Retained Earnings 15 15 18 22 19
Other Equity 0 0 0 0 0
Treasury Stock 1 1 0 0 0
Total Shareholder's Equity 16 17 19 23 21
Total Liabilities & Shareholder's Equity 20 21 24 30 27
Total Common Equity 16 17 19 23 21
Shares Outstanding 22.90 23.40 23.40 23.40 23.40
Book Value Per Share 0.70 0.71 0.81 0.97 0.88

Fiscal Year End for PharmaBio Serv Inc falls in the month of October.

All items in Millions except Per Share data.

1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Assets          
Cash & Equivalents 16 15 15 14 15
Receivables 2 4 5 5 4
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 0 0 1 0 0
Total Current Assets 19 19 20 19 20
Net Property & Equipment 0 0 0 0 0
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 0 0 0 0 0
Deposits & Other Assets 0 0 0 0 0
Total Assets 19 20 20 20 21
Liabilities & Shareholders Equity 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 1 1 2 2 1
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 1 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 1 1 1 0
Other Current Liabilities 2 0 0 0 0
Total Current Liabilities 4 2 2 2 2
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 1 1 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 5 4 4 4 4
Shareholders Equity 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 2 2 2 2 2
Retained Earnings 13 15 15 14 16
Other Equity 0 0 0 0 0
Treasury Stock 1 1 1 1 1
Total Shareholder's Equity 14 16 16 16 17
Total Liabilities & Shareholder's Equity 19 20 20 20 21
Total Common Equity 14 16 16 16 17
Shares Outstanding 22.90 22.90 22.90 22.90 23.40
Book Value Per Share 0.62 0.70 0.71 0.68 0.73